Feed Top Reports Pricing

⌘K

17:19:10·44d

SECFiling

SEC Form DEF 14A filed by Chemours Company

CC· Chemours Company

Industrials

Full content unavailable. See the original source below.

Original source

Companies

CC
Chemours Company
Industrials

Recent analyst ratings

Mar 27UpdateMizuho$19.00
Jan 28UpdateTruist$27.00
Jul 9UpdateUBS$30.00
Jun 7UpdateMizuho$25.00
Apr 9UpdateBMO Capital Markets$34.00
Mar 5UpdateUBS$21.00

Related

PR2d
Chemours Announces Dates for First Quarter 2026 Earnings Release and Webcast Conference Call
INSIDER22d
SEC Form 4 filed by Mather Courtney
SEC28d
Amendment: SEC Form SCHEDULE 13G/A filed by Chemours Company
SEC42d
Chemours Company filed SEC Form 8-K: Entry into a Material Definitive Agreement, Other Events, Creation of a Direct Financial Obligation, Financial Statements and Exhibits
PR42d
The Chemours Company Announces Completion of Private Offering of $700,000,000 Aggregate Principal Amount of 7.875% Senior Unsecured Notes Due 2034
SEC44d
SEC Form DEFA14A filed by Chemours Company
INSIDER51d
SVP, GC & Corp. Secretary Wellman Kristine M covered exercise/tax liability with 3,359 shares and was granted 25,708 shares, increasing direct ownership by 43% to 73,751 units (SEC Form 4)
INSIDER51d
Chief Executive Officer Dignam Denise covered exercise/tax liability with 22,220 shares and was granted 169,538 shares, increasing direct ownership by 78% to 335,314 units (SEC Form 4)

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releases Analyst ratings Insider trading FDA SEC RSS feeds

Top lists

Trending By market cap Active companies Analyst upgrades Insider purchases FDA approvals SEC filings Sectors Market reports

Company

About Pricing Publish with us Contact

Legal

Terms of use Privacy policy Cookie policy

© 2026 quantisnow.com · Democratizing insights since 2022